Today: 1 May 2026
Browse Category

Mergers and Acquisitions 15 December 2025 - 24 December 2025

Dynavax Technologies (DVAX) Stock Jumps on Sanofi’s $2.2B Cash Buyout Offer: Latest News, Forecasts, and What Comes Next (Dec. 24, 2025)

Dynavax Technologies (DVAX) Stock Jumps on Sanofi’s $2.2B Cash Buyout Offer: Latest News, Forecasts, and What Comes Next (Dec. 24, 2025)

Sanofi announced a deal to acquire Dynavax Technologies for $2.2 billion in cash, offering $15.50 per share—a 39% premium to Dynavax’s prior close. DVAX stock jumped about 37% premarket to near the offer price. Dynavax’s board approved the transaction. Closing is expected in Q1 2026, pending regulatory and shareholder approvals.
24 December 2025
···
Clearwater Analytics (CWAN) Stock News on Dec. 23, 2025: $24.55 Take-Private Deal, Go‑Shop Window, Analyst Reactions, and What Investors Should Watch

Clearwater Analytics (CWAN) Stock News on Dec. 23, 2025: $24.55 Take-Private Deal, Go‑Shop Window, Analyst Reactions, and What Investors Should Watch

Clearwater Analytics shares traded at $24.06 on December 23, just below the $24.55-per-share cash buyout price set in an $8.4 billion take-private deal led by Permira and Warburg Pincus. The agreement includes a go-shop period through January 23, 2026, allowing Clearwater to seek higher offers.
23 December 2025
·
Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $14.50 Cash Buyout, Analyst Downgrades, and What Investors Watch Next (Dec. 22, 2025)

Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $14.50 Cash Buyout, Analyst Downgrades, and What Investors Watch Next (Dec. 22, 2025)

BioMarin agreed to acquire Amicus Therapeutics for $14.50 per share in cash, valuing Amicus at $4.8 billion. FOLD traded near $14.22 on December 22, reflecting market expectations for deal completion and timing. The transaction is expected to close in Q2 2026, pending regulatory and shareholder approvals. Either party may terminate if not closed by June 19, 2026, with a $175 million breakup fee.
22 December 2025
··
ABIVAX Société Anonyme Stock (ABVX) Jumps on Fresh Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Takes EffectABIVAXABIVAX Société Anonyme Stock (ABVX) Jumps on Fresh Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Takes Effect

ABIVAX Société Anonyme Stock (ABVX) Jumps on Fresh Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Takes EffectABIVAXABIVAX Société Anonyme Stock (ABVX) Jumps on Fresh Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Takes Effect

Abivax shares jumped as much as 14% to €114.4 in Paris on Monday after reports of renewed takeover interest from Eli Lilly and the company’s addition to the Nasdaq Biotechnology Index. French outlet La Lettre reported Lilly representatives met with French Treasury officials this month about a potential deal, though Reuters said it could not confirm the meeting. Neither company commented on the rumors.
22 December 2025
··
ABIVAX (ABVX) Stock Surges on Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Kicks In — News, Forecasts and Outlook (Dec. 22, 2025)

ABIVAX (ABVX) Stock Surges on Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Kicks In — News, Forecasts and Outlook (Dec. 22, 2025)

Abivax shares jumped about 10% to $126 in early U.S. premarket trading after reports of renewed takeover speculation involving Eli Lilly and confirmation of Abivax’s addition to the Nasdaq Biotechnology Index. French media said Lilly representatives met with France’s Treasury about a possible acquisition, though Reuters could not confirm the meeting. Both companies declined to comment on the rumors.
22 December 2025
····
Amicus Therapeutics (FOLD) Stock Week Ahead: $14.50 BioMarin Buyout Puts the Deal Spread—and New Filings—Front and Center (Dec. 22–26, 2025)

Amicus Therapeutics (FOLD) Stock Week Ahead: $14.50 BioMarin Buyout Puts the Deal Spread—and New Filings—Front and Center (Dec. 22–26, 2025)

BioMarin Pharmaceutical agreed Friday to acquire Amicus Therapeutics for $14.50 per share in cash, valuing the company at $4.8 billion. FOLD shares closed near $14.18 after jumping 30% on the news. The deal is expected to close in Q2 2026, pending shareholder and regulatory approvals. Amicus disclosed a $175 million breakup fee and a June 19, 2026 outside date.
22 December 2025
····
ServiceNow (NOW) Stock Week Ahead: Armis Deal Chatter, Moveworks Integration, 5-for-1 Split Fallout, and Fresh Analyst Targets

ServiceNow (NOW) Stock Week Ahead: Armis Deal Chatter, Moveworks Integration, 5-for-1 Split Fallout, and Fresh Analyst Targets

ServiceNow shares traded near $155 (split-adjusted) as of December 21, 2025, after a volatile week driven by reports of advanced talks to acquire Armis for up to $7 billion. The stock fell sharply on December 15 amid concerns over the deal’s size and a key analyst downgrade. ServiceNow recently completed a 5-for-1 stock split and closed its largest acquisition to date, Moveworks. No formal confirmation of the Armis deal has been issued.
21 December 2025
··
Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $14.50 Cash Buyout, Latest News, Analyst Forecasts, and What Comes Next (Dec. 21, 2025)

Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $14.50 Cash Buyout, Latest News, Analyst Forecasts, and What Comes Next (Dec. 21, 2025)

BioMarin Pharmaceutical agreed to acquire Amicus Therapeutics for $14.50 per share in cash, valuing Amicus at $4.8 billion. Amicus closed at $14.20 on Dec. 19, just below the buyout price. The deal, approved by both boards, is expected to close in Q2 2026 pending regulatory and shareholder approval. BioMarin plans to fund the purchase with cash and about $3.7 billion in new debt.
21 December 2025
··
Amicus Therapeutics (FOLD) Stock Jumps on BioMarin’s $4.8B Buyout: Latest News, Forecasts, and Deal Analysis as of Dec. 20, 2025

Amicus Therapeutics (FOLD) Stock Jumps on BioMarin’s $4.8B Buyout: Latest News, Forecasts, and Deal Analysis as of Dec. 20, 2025

BioMarin Pharmaceutical will acquire Amicus Therapeutics in an all-cash deal valued at $4.8 billion, offering $14.50 per share. Amicus stock surged about 30% after the Dec. 19 announcement, trading near $14.18 as of Dec. 20. The deal awaits regulatory and shareholder approval, with closing expected in Q2 2026. Trading volume spiked as investors focused on merger risk and timing.
21 December 2025
··
Warner Bros. Discovery Stock (WBD) Forecast: Netflix Merger vs. Paramount’s $30 Bid Puts Shares in Deal-Driven Limbo (Dec. 20, 2025)

Warner Bros. Discovery Stock (WBD) Forecast: Netflix Merger vs. Paramount’s $30 Bid Puts Shares in Deal-Driven Limbo (Dec. 20, 2025)

Warner Bros. Discovery’s board urged shareholders to reject Paramount Skydance’s $30-per-share all-cash tender offer, citing financing concerns and a potential $4.3 billion cost if the Netflix deal is abandoned. WBD stock closed at $27.77 on Dec. 19, near Netflix’s $27.75 per-share offer. Netflix reaffirmed its commitment to its $72 billion deal. Paramount continues to push its cash bid.
21 December 2025
···
Communication Services Stocks News Today (Dec. 20, 2025): Meta, Alphabet, Netflix–Warner Deal Shockwaves, and Telecom M&A Set Up 2026

Communication Services Stocks News Today (Dec. 20, 2025): Meta, Alphabet, Netflix–Warner Deal Shockwaves, and Telecom M&A Set Up 2026

Meta’s board lost Dina Powell McCormick after eight months, with no replacement planned, Reuters reported Dec. 19. Facebook is testing link-sharing limits for non-paying users, according to the Guardian. The XLC ETF’s top holdings remain Meta and Alphabet, with Warner Bros. Discovery now among the largest entertainment weights. Recent XLC net asset value sits near $116.
20 December 2025
··········
Qualcomm (QCOM) Stock News Today: Alphawave Semi Acquisition Closes, Analyst Targets Update, and 2026 AI Data-Center Outlook (Dec. 19, 2025)

Qualcomm (QCOM) Stock News Today: Alphawave Semi Acquisition Closes, Analyst Targets Update, and 2026 AI Data-Center Outlook (Dec. 19, 2025)

Qualcomm closed its $2.4 billion acquisition of Alphawave Semi on December 19, ahead of schedule, and named Alphawave CEO Tony Pialis to lead its data center business. Alphawave shares were delisted from the London Stock Exchange Friday morning. Qualcomm stock rose 1.37% to $176.58 as investors weighed the deal’s impact and debated the company’s valuation.
19 December 2025
··
Howard Hughes Holdings (HHH) Stock Falls on Dec. 19, 2025 After $2.1B Vantage Deal: Latest News, Analyst Forecasts, and Key Risks

Howard Hughes Holdings (HHH) Stock Falls on Dec. 19, 2025 After $2.1B Vantage Deal: Latest News, Analyst Forecasts, and Key Risks

Howard Hughes Holdings shares fell about 5% to $79–$80 on Friday after announcing a $2.1 billion deal to acquire Vantage Group Holdings. The company will finance the purchase with cash and up to $1 billion in preferred stock issued to Pershing Square. The deal is expected to close in Q2 2026, pending regulatory approvals. Investors reacted to the company’s shift toward a diversified holding model.
19 December 2025
··
TWO-PA Stock News Today (Dec. 17, 2025): UWM’s $1.3B Two Harbors Deal Puts Series A Preferred in Focus — What Holders Need to Know

TWO-PA Stock News Today (Dec. 17, 2025): UWM’s $1.3B Two Harbors Deal Puts Series A Preferred in Focus — What Holders Need to Know

UWM Holdings will acquire Two Harbors Investment Corp. in an all-stock deal valued at $1.3 billion, the companies announced December 17. Each Two Harbors Series A preferred share (TWO-PA) will be exchanged one-for-one into a newly issued UWM Series A preferred share at closing, expected in Q2 2026 pending approvals. Common shareholders will receive 2.3328 UWMC shares per TWO share.
17 December 2025
···
ABIVAX Société Anonyme (ABVX) Stock News on Dec. 16, 2025: Shares Slide After Q3 Loss Widens, While Analysts Keep Buy Calls and M&A Talk Lingers

ABIVAX Société Anonyme (ABVX) Stock News on Dec. 16, 2025: Shares Slide After Q3 Loss Widens, While Analysts Keep Buy Calls and M&A Talk Lingers

Abivax shares fell about 5% in U.S. and Paris trading after reporting a nine-month net loss of €254.1 million, up from €136.9 million a year earlier. Cash and cash equivalents stood at €589.7 million as of September 30, expected to fund operations into Q4 2027. Investors weighed widening losses against a strong cash position and ongoing takeover speculation.
16 December 2025
···
Coca-Cola Stock (NYSE: KO) News Today: Costa Coffee Sale Talks, CEO Succession, Dividend, and Analyst Price Targets (Dec. 15, 2025)

Coca-Cola Stock (NYSE: KO) News Today: Costa Coffee Sale Talks, CEO Succession, Dividend, and Analyst Price Targets (Dec. 15, 2025)

Coca-Cola shares traded near $70.72 on Dec. 15, 2025, up 0.28% in a narrow range. Reuters reports last-ditch talks with TDR Capital over a potential Costa Coffee sale, with price disagreements threatening the deal. The company is also managing a CEO transition and a dividend payout. Wall Street maintains a modestly positive outlook for KO.
15 December 2025
··
ServiceNow (NOW) Stock Slides on Armis Deal Rumors, KeyBanc Downgrade, and a Looming 5-for-1 Split

ServiceNow (NOW) Stock Slides on Armis Deal Rumors, KeyBanc Downgrade, and a Looming 5-for-1 Split

ServiceNow shares fell about 11% to $767 Monday after reports the company is in advanced talks to acquire cybersecurity startup Armis for up to $7 billion. The drop followed a KeyBanc analyst downgrade citing AI disruption risks. The selloff comes days before ServiceNow’s planned 5-for-1 stock split. ServiceNow declined to comment on the reported deal.
15 December 2025
··
Aegon Ltd Stock (AEG) Today: Transamerica Rebrand, U.S. Relocation Plan, Buybacks, and the UK Sale Watchlist (Dec. 15, 2025)

Aegon Ltd Stock (AEG) Today: Transamerica Rebrand, U.S. Relocation Plan, Buybacks, and the UK Sale Watchlist (Dec. 15, 2025)

Aegon Ltd shares traded near $7.63 midday Monday in New York as the company pursues a major shift to move its headquarters and legal seat to the U.S. and rebrand as Transamerica Inc. by 2028. The stock fell 8% in Amsterdam after the plan was announced, with investors weighing new financial targets, a buyback schedule, and a strategic review of the UK business.
15 December 2025
··
ZIM Stock (NYSE: ZIM) in Focus: Takeover Bids, Proxy Fight, Dividend Signals, and Analyst Forecasts (Dec. 15, 2025)

ZIM Stock (NYSE: ZIM) in Focus: Takeover Bids, Proxy Fight, Dividend Signals, and Analyst Forecasts (Dec. 15, 2025)

ZIM Integrated Shipping shares fell 5.4% to $18.76 on Dec. 15, 2025, amid takeover speculation and a pending shareholder vote. The board confirmed a strategic review after receiving a non-binding acquisition proposal from CEO Eli Glickman and Rami Ungar. Reports say MSC and Hapag-Lloyd have also submitted bids. Any sale would require shareholder and Israeli government approval.
15 December 2025
···
Compass Group PLC Stock (CPG.L) News, Forecasts and Analysis on 15 December 2025: Vermaat Deal Cleared as Analysts Target a Rebound

Compass Group PLC Stock (CPG.L) News, Forecasts and Analysis on 15 December 2025: Vermaat Deal Cleared as Analysts Target a Rebound

Compass Group shares hovered near 2,322p on Monday, close to the lower end of their 52-week range after the EU cleared its €1.5bn Vermaat acquisition. The stock is down 12.6% over 12 months. FY25 results showed $46.1bn revenue, $3,335m operating profit, and 8.7% organic growth. Several brokers say the pullback has improved the stock’s entry point.
15 December 2025
··
1 2 3 4 5 … 7

Stock Market Today

  • Australian Shares Expected to Rise as US Markets Hit Record Highs and Corporate Earnings Impress
    May 1, 2026, 1:25 AM EDT. Australian sharemarket futures surged 131 points to 8,677, reflecting optimism after Wall Street's record-breaking session where the Dow Jones rose 1.62% and the S&P 500 posted its strongest monthly gain since November 2020. Persistent gains in tech and industrial giants, including Atlassian, Apple, and Caterpillar, bolstered investor confidence. Brent crude oil briefly hit $126 a barrel amid Middle East tensions before settling down slightly. The Australian dollar strengthened to 72 US cents, with Bitcoin modestly up. Locally, attention shifts to March producer price indexes from the Australian Bureau of Statistics, while US economic data showed 2% GDP growth in Q1 2026 alongside rising inflation at 3.5%. The mix of robust earnings and macroeconomic signals sets the stage for a rally in Australian equities.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 01.05.2026

1 May 2026
LIVEMarkets rolling coverageStarted: May 1, 2026, 12:00 AM EDTUpdated: May 1, 2026, 1:31 AM EDT Australian Shares Expected to Rise as US Markets Hit Record Highs and Corporate Earnings Impress May 1, 2026, 1:25 AM EDT. Australian sharemarket futures surged 131 points to 8,677, reflecting optimism after Wall Street's record-breaking session where the Dow Jones rose 1.62% and the S&P 500 posted its strongest monthly gain since November 2020. Persistent gains in tech and industrial giants, including Atlassian, Apple, and Caterpillar, bolstered investor confidence. Brent crude oil briefly hit $126 a barrel amid Middle East tensions before settling down slightly.
Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Go toTop